Cresco Labs Inc. (CRLBF) Cost of Revenue (2020 - 2026)

Cresco Labs (CRLBF) has reported Cost of Revenue for 7 consecutive years, with $86.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cost of Revenue rose 7.5% year-over-year to $86.4 million; the trailing twelve-month figure through Jun 2026 stood at $326.1 million (down 5.69% YoY), and the FY2025 full-year result was $331.3 million, down 7.95% from the prior year.
• Cost of Revenue improved to $86.4 million in Q2 2026 per CRLBF's latest filing, from $75.9 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $111.9 million in Q4 2022 and bottomed at $75.9 million in Q1 2026.
• Historically, Cost of Revenue has averaged $94.3 million across 5 years, with a median of $92.0 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Cost of Revenue climbed 17.07% in 2022, then declined 19.43% in 2024.
• Over 5 years, Cost of Revenue stood at $111.9 million in 2022, then slipped by 17.68% to $92.1 million in 2023, then retreated by 0.23% to $91.9 million in 2024, then decreased by 14.86% to $78.2 million in 2025, then rose by 10.43% to $86.4 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $86.4 million, $75.9 million, and $78.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.